Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
As per available reports about 6 relevant journals, 436 Scientific conference proceedings and 108 National symposiums are presently dedicated exclusively to PSA Test and and about 157 Open Access Articles are being published on PSA.
Prostate-specific antigen, or PSA, is a protein produced by cells of the prostate gland.Today, the interdisciplinary care of prostate cancer has become a reality, and urologists along with radiation, surgical, and medical oncologists are all involved in the management of these patients. In order to provide optimal care, it is essential that all members of the treatment team stay up-to-date on current trends and emerging data, not just in their own area, but also in the related specialties such as Prostate Cancer: What All Men Must Know, Prostate cancer: Current topics and future perspectives, Latest Research on Prostate Cancer, Treating Prostate Cancer and Prostate Cancer: Bone Metastases.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance
PSA Test Conference provides the scope for opportunities to learn progressed by international scientists and academicians.PSA test measures the amount of prostate-specific antigen (PSA) in blood. Prostate specific antigen is a protein produced by prostate cells. To perform PSA test a blood sample is needed. The results are usually reported as nanograms of PSA per millilitre (ng/mL) of blood. In addition to prostate cancer, a number of benign (not cancerous) conditions can cause a man’s PSA level to rise. The most frequent benign prostate conditions that cause an elevation in PSA level are prostatitis (inflammation of the prostate) and benign prostatic hyperplasia (BPH) (enlargement of the prostate). There is no evidence that prostatitis or BPH leads to prostate cancer, but it is possible for a man to have one or both of these conditions and to develop prostate cancer as well. There is no specific normal or abnormal level of PSA in the blood. In the past, most doctors considered PSA levels of 4.0 ng/mL and lower as normal. Therefore, if a man had a PSA level above 4.0 ng/mL, doctors would often recommend a prostate biopsy to determine whether prostate cancer was present. The higher a man’s PSA level, the more likely it is that he has prostate cancer. Moreover, continuous rise in a man’s PSA level over time may also be a sign of prostate cancer.
The Global PSA Testing Market was $250 million in 2014. The PSA Testing Market is driven by the advancements in technology and the increasing population in the age bracket of 50-64 years which is most affected by Prostate Cancer. The highest growth is seen in Asia-pacific region, while North America holds the biggest market share.
International symposium and workshops
Prostate cancer world conference , August 18-21 -2015, Cairns, Queensland, Australia.
Global Congress on Prostate Cancer , February5-7,2015 -Rome, Italy.
Genitourinary Cancers Symposium, February 26-28, 2015, Orlando, Florida.
Advanced Prostate Cancer Consensus Conference, March 12-14, 2015, St Galen Switzerland.
List of Best International Conferences
Pancreatic and Colorectal Cancer Conference
March 29-30, 2016 Atlanta, USA.
4th Blood Malignancies Conference
April 18-20, 2016 Dubai, UAE.
Gynecologic Oncology Conference,
May 19-21, 2016 San Antonio, USA.
2nd Antimicrobial Agents and Chemotherapy Conference
June 6-7, 2016 Dallas, USA.
Cancer Diagnostics Conference
June 13-15, 2016 Rome, Italy.
10 Global Oncologists Conference
July 11-13, 2016 Cologne, Germany.
11th Oncology and Oncologists Conference
July 11-13, 2016 Kuala Lumpur, Malaysia.
Melanoma and Carcinoma Conference
July 14-15, 2016 Brisbane, Australia.
Neuro Onclogy Conference
July 21-23, 2016 Brisbane, Australia.
Thyroid Cancer Conference
Aug 1-3, 2016 Toronto, Canada.
Oral, Mouth and Throat Cancer Conference
Aug 18-20, 2016 Portland, Oregon.
Molecular & Cancer Biomarkers Conference
Sept 15-17, 2016 Berlin, Germany.
Cervical Cancer Conference
Sept 22-23, 2016 Vienna, Austria.
Radiation Oncology Conference
Sep 26-28, 2016 Valencia, Spain.
12th Cancer Therapy Conference
Sept 26-28, 2016 London, UK.
13th Oncologists and Cancer Therapy Conference
Oct 17-19, 2016 Dubai, UAE.
Nov 3-4, 2016 Valencia, Spain.
Leukemia and Bonemarrow Tranplantation Conference
Nov 10-12, 2016 Istanbul, Turkey.
14th Cancer Therapy Conference
Dec 8-10, 2016 Baltimore, USA.
Relevant Society and Associations
American Cancer Society.
Prostate Cancer Foundation.
Cancer Research UK.
British Association of Urological Surgeons (BAUS).
National Cancer Institute.
Prostate Cancer UK.
Prostate Cancer Canada.
Australian Prostate cancer Research Centre.
Prostate Cancer Foundation of Australia.
Urological Association of Asia and Iranian.
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising